Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Total revenue	$ 123,101	$ 116,743	$ 339,795	$ 306,550
Cost of services	37,041	32,216	107,286	92,645
Gross profit	86,060	84,527	232,509	213,905
Research and development	17,366	19,829	56,826	47,485
Selling, general and administrative	79,122	67,949	229,750	165,262
Impairment loss	0	0	31,287	0
(Loss) income from operations	(10,428)	(3,251)	(85,354)	1,158
Non-operating expense, net
Change in fair value of financial liabilities	0	(3,401)	2,760	(2,320)
Interest expense, net	(1,779)	(562)	(3,681)	(2,019)
Loss on extinguishment of debt	0	0	(6,565)	0
Other (expense) income, net	(94)	(174)	(138)	274
Total non-operating expense, net	(1,873)	(4,137)	(7,624)	(4,065)
Loss before income taxes	(12,301)	(7,388)	(92,978)	(2,907)
Income tax expense	(26)	(247)	(405)	(448)
Net loss	(12,327)	(7,635)	(93,383)	(3,355)
Other comprehensive loss, net of tax
Unrealized (loss) gain related to available for sale securities, net	(453)	190	(1,047)	172
Comprehensive loss	$ (12,780)	$ (7,445)	$ (94,430)	$ (3,183)
Weighted-average shares outstanding of Class A common stock - Basic (in shares)	29,880,144	28,797,730	29,643,799	28,505,657
Weighted-average shares outstanding of Class A common stock - Diluted (in shares)	29,880,144	28,797,730	29,643,799	28,505,657
Loss per share, Class A common stock - Basic (in dollars per share)	$ (0.41)	$ (0.27)	$ (3.15)	$ (0.12)
Loss per share, Class A common stock - Diluted (in dollars per share)	$ (0.41)	$ (0.27)	$ (3.15)	$ (0.12)
Class A Common Stock
Other comprehensive loss, net of tax
Weighted-average shares outstanding of Class A common stock - Basic (in shares)	29,880,144	28,797,730	29,643,799	28,505,657
Weighted-average shares outstanding of Class A common stock - Diluted (in shares)	29,880,144	28,797,730	29,643,799	28,505,657
Loss per share, Class A common stock - Basic (in dollars per share)	$ (0.41)	$ (0.27)	$ (3.15)	$ (0.12)
Loss per share, Class A common stock - Diluted (in dollars per share)	$ (0.41)	$ (0.27)	$ (3.15)	$ (0.12)
Diagnostic test revenue:
Total revenue	$ 120,059	$ 113,523	$ 333,244	$ 299,382
Other revenue
Total revenue	$ 3,042	$ 3,220	$ 6,551	$ 7,168